INDUCTION CHEMOTHERAPY USING DOXORUBICIN AND CISPLATIN FOLLOWED BY COMBRETASTATIN A4 PHOSPHATE AND RADIATION THERAPY IN TREATING PATIENTS WITH NEWLY DIAGNOSED REGIONALLY ADVANCED ANAPLASTIC THYROID CANCER: